We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$437M
AUM Growth
+$30.2M
Cap. Flow
+$3.43M
Cap. Flow %
0.78%
Top 10 Hldgs %
24.44%
Holding
187
New
7
Increased
67
Reduced
70
Closed
10

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$4.88M
2
IBM icon
IBM
IBM
+$2.54M
3
GE icon
GE Aerospace
GE
+$1.57M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$846K
5
UNH icon
UnitedHealth
UNH
+$594K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.28M
2
NVS icon
Novartis
NVS
+$2.2M
3
BA icon
Boeing
BA
+$1.69M
4
PFE icon
Pfizer
PFE
+$1.27M
5
AAPL icon
Apple
AAPL
+$529K

Sector Composition

Rank Sector Weight
1 Financials 15.2%
2 Technology 13.51%
3 Healthcare 13.47%
4 Consumer Discretionary 11.17%
5 Industrials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
51
Wells Fargo
WFC
$261B
$3.74M 0.86%
61,670
+620
+1% +$35K
JWN
52
DELISTED
Nordstrom
JWN
$3.73M 0.85%
78,633
+6,392
+9% +$275K
T icon
53
AT&T
T
$153B
$3.46M 0.79%
117,686
+6,193
+6% +$169K
TJX icon
54
TJX Companies
TJX
$172B
$3.39M 0.78%
88,648
+2,854
+3% +$103K
BP icon
55
BP
BP
$108B
$3.24M 0.74%
84,169
+1,426
+2% +$51.7K
CSCO icon
56
Cisco
CSCO
$436B
$3.21M 0.73%
83,831
+644
+0.8% +$23K
LH icon
57
Labcorp
LH
$23.1B
$3.08M 0.71%
22,500
-41
-0.2% -$5.42K
EXC icon
58
Exelon
EXC
$47B
$3.03M 0.69%
107,817
+4,449
+4% +$128K
ELV icon
59
Elevance Health
ELV
$82.9B
$2.9M 0.66%
12,880
-851
-6% -$181K
IWP icon
60
iShares Russell Mid-Cap Growth ETF
IWP
$20.1B
$2.88M 0.66%
47,736
+2,550
+6% +$150K
MU icon
61
Micron Technology
MU
$977B
$2.84M 0.65%
68,965
-1,575
-2% -$67.8K
TGT icon
62
Target
TGT
$63.4B
$2.68M 0.61%
41,101
+1,652
+4% +$99.7K
DD icon
63
DuPont de Nemours
DD
$18.3B
$2.35M 0.54%
13,003
+1,176
+10% +$212K
ETN icon
64
Eaton
ETN
$156B
$2.28M 0.52%
28,840
-1,541
-5% -$120K
PEP icon
65
PepsiCo
PEP
$185B
$2.14M 0.49%
17,840
-629
-3% -$71.8K
SBUX icon
66
Starbucks
SBUX
$119B
$2.11M 0.48%
36,759
+6,730
+22% +$381K
STZ icon
67
Constellation Brands
STZ
$22.9B
$2.07M 0.47%
9,045
+100
+1% +$21.6K
RTN
68
DELISTED
Raytheon Company
RTN
$1.99M 0.46%
10,598
-873
-8% -$163K
SCHW
69
Charles Schwab
SCHW
$178B
$1.96M 0.45%
38,085
-1,675
-4% -$78.7K
SYY icon
70
Sysco
SYY
$38.6B
$1.88M 0.43%
30,995
-1,060
-3% -$60.1K
UNH icon
71
UnitedHealth
UNH
$383B
$1.88M 0.43%
8,514
+2,805
+49% +$594K
BHP icon
72
BHP
BHP
$204B
$1.88M 0.43%
45,730
+3,055
+7% +$115K
GOOG icon
73
Alphabet (Google) Class C
GOOG
$4.29T
$1.88M 0.43%
35,860
-3,120
-8% -$159K
MMM icon
74
3M
MMM
$83B
$1.84M 0.42%
9,330
+692
+8% +$133K
AGN
75
DELISTED
Allergan plc
AGN
$1.81M 0.42%
11,092
+70
+0.6% +$12.6K

Similar funds

Stonebridge Capital Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Stonebridge Capital Advisors held 187 positions worth $437M, up 7.4% from $407M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Stonebridge Capital Advisors's Q4 2017 filing shows 7 new, 67 increased, 70 reduced and 10 closed positions. Its largest new stake was Caterpillar: 1,734 shares worth $273K. The largest sale was AbbVie, an estimated $2.28M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Stonebridge Capital Advisors's largest Q4 2017 buy was Caterpillar: 1,734 shares worth $273K.
  • Stonebridge Capital Advisors added most to Medtronic in Q4 2017, an estimated $4.88M increase.
  • Stonebridge Capital Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $2.28M.
  • Stonebridge Capital Advisors fully exited Novartis in Q4 2017, selling an estimated $2.2M.
  • Stonebridge Capital Advisors's ten largest holdings make up 24% of its $437M portfolio in Q4 2017.
  • Stonebridge Capital Advisors opened 7 new positions and closed 10 in Q4 2017.
  • Stonebridge Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $437M.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2017, filed 15 Feb 2018.